Roche en route to first continuous delivery treatment for nAMD in Europe
By Catherine Eckford (European Pharmaceutical Review)
Amgen to build $600m science and innovation centre in the US
By Dominic Tyer (European Pharmaceutical Review)
Merck’s health business gains new Global Head of R&D
By Dominic Tyer (European Pharmaceutical Review)
Critical Medicines Act ‘must prioritise’ EU pharmaceutical manufacturing competitiveness
By Catherine Eckford (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)